This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Christopher Towler: Innovator in Quinazolinone Derivatives
Introduction
Christopher Towler is a notable inventor based in Quincy, MA (US). He has made significant contributions to the field of medicinal chemistry, particularly through his work on quinazolinone derivatives. His innovative approach has led to advancements in the development of vanilloid antagonists.
Latest Patents
Towler holds a patent for "Quinazolinone derivatives useful as vanilloid antagonists." This patent describes a new polymorphic form of 4-(7-Hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile and outlines a method for preparing it. This invention has the potential to impact therapeutic applications significantly.
Career Highlights
Christopher Towler is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative drug development and contribute to the advancement of pharmaceutical science.
Collaborations
Towler has collaborated with esteemed colleagues, including Weichun Chen and Hong-Yong Kim. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Christopher Towler's contributions to the field of medicinal chemistry, particularly through his patent on quinazolinone derivatives, highlight his role as an innovator in the pharmaceutical industry. His work continues to pave the way for future advancements in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile